In the ADVANCE trial of 3,865 people with T2D and established CVD risk factors, IL-6 was associated with future fatal and non-fatal cardiovascular events, after adjusting for other inflammatory markers including fibrinogen and C-reactive protein (CRP [28]). This evidence concerns the gene CRP and type 2 diabetes mellitus.